Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

Clinical trial NCT07008469 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07008469
Sponsor: Avidity Biosciences, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Myotonic Dystrophy Type 1 DM1 Myotonic Dystrophy Myotonia Myotonic Dystrophy 1 Myotonic Disorders Steinert Myotonic Dystrophy Steinert Disease

Start date: 2025-06-26
Primary completion: 2030-10-01
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.